Weekly Briefing: biotech, agtech and regtech drive £112.7M in UK startup funding (2–6 Mar 2026)
🎧 Prefer to listen? Play this week's Startupmag Briefing below:
It's Friday, 6 March, and this is your Startupmag Weekly Briefing.
This week’s UK funding activity was led by large biotech and industrial rounds, with agritech and regulatory technology also notable. Startups raised a combined £112.7M across a range of stages from pre-seed to Series D.
Autonomy pushes toward real‑world deployment
Autonomy and coordination technology for vehicles and drones dominated this week’s rounds, with funding tied to moving pilots into real‑world sites and government demonstrations. Investors favoured systems built for industrial settings and for contested environments where GPS or communications may fail, signalling a shift from lab proofs to field readiness.
Oxford‑based Oxa closed a £77 million Series D first close led by the National Wealth Fund to commercialise its autonomous vehicle software for industrial sites. The capital is earmarked to accelerate roll‑out of the Oxa Driver and Foundry toolchain across ports, airports and manufacturing. Cambridge’s Mutable Tactics raised £1.6 million to build a decision layer that lets drone fleets coordinate and make local decisions if communications or GPS are degraded; the round will fund engineering hires and government collaboration and demonstrations.
Taken together, the rounds underline a practical investor focus: public backing and government demos recur, and startups are prioritising robustness and site deployment over purely academic milestones as they move towards commercial operations.
This week's Mobility / Robotics deals:
Oxford-based Oxa closed a £77m Series D first close led by the National Wealth Fund to commercialise its autonomous vehicle software for industrial sites. The capital will accelerate deployment of its Oxa Driver and Foundry toolchain across sectors such as ports, airports and manufacturing.
Mutable Tactics raised £1.6m to develop a decision‑layer that lets drone fleets coordinate and make local decisions when communications or GPS fail. The pre‑seed will grow the Cambridge engineering team and fund government collaboration and demonstrations.
Sustainable materials and ag‑biotech scale up
Investors deployed capital across sustainable materials and agricultural biotech this week, from fermentation‑derived packaging to AI‑designed molecular glues and gene editing. The common thread is moving laboratory breakthroughs towards manufacturable products and field‑ready crop traits.
London’s Shellworks raised £11.25 million to scale production of Vivomer, a fermentation‑derived biodegradable packaging material, and to expand manufacturing and commercial partnerships so it can compete on cost with conventional materials. Cambridge startup Bindbridge secured £2.8 million to develop BRIDGE, an AI platform for designing molecular glues for crop protection and to support partnerships with agrochemical firms and early lab testing. Norwich ag‑biotech ALORA closed a funding round, amount undisclosed, to validate gene‑edited traits that shift plant energy from defence to yield; early field and controlled‑environment results were described as promising.
The diversity of approaches is notable: investors are backing both hard manufacturing scale‑up and biotech pathways, and partnerships with established chemical and agricultural players are already forming as companies move from proofs of concept towards commercial deals.
This week's Greentech / Agtech / Materials deals:
London biomaterials company Shellworks raised £11.25m (USD $15m) in Series A to scale production of Vivomer, a fermentation‑derived biodegradable packaging material. The funding will expand manufacturing and commercial partnerships to make Vivomer cost‑competitive with conventional materials.
Cambridge startup Bindbridge secured £2.8m to develop BRIDGE, an AI platform for designing molecular glues for crop protection. The funding will support partnerships with agrochemical firms and early lab testing of agricultural molecular glue candidates.
Norwich ag‑biotech ALORA closed a funding round (amount not disclosed) to validate gene‑edited traits that shift plant energy from defence to yield, with early field and controlled environment results showing promising yield gains. The investment will support broader trait validation and commercial discussions.
From discovery platforms to clinical infrastructure
This week’s funding highlights the sector’s breadth, spanning drug discovery platforms, lab infrastructure and AI‑enabled health products. The rounds reflect continued appetite for AI applied to discovery, investment in physical lab capacity and tools that translate biological data into actionable products.
Cardiff‑based Antiverse raised £7 million to scale its AI‑driven antibody discovery platform and advance candidates towards later‑stage preclinical work while supporting collaborations with pharma partners. London’s Outpost Bio secured £2.6 million pre‑seed to build automated experimental and modelling platforms that predict drug–microbiome interactions and to generate human‑derived functional data for pharma and food partners. LifeCellsNI received £590,000 to establish Northern Ireland’s first HTA‑licensed cryogenic biobank and processing facility; funds are earmarked for cleanroom installation, licensing and a planned 2026 operational launch. ROXFIT closed £1.9 million to expand its AI‑powered training and wearable analytics platform for hybrid athletes and to accelerate product development and ambassador partnerships.
Collectively, the rounds show investors backing both platform science and nearer‑term clinical and consumer applications, and they underline regional strength across the UK from Cardiff to London and Northern Ireland.
This week's Biotech & Healthtech deals:
Cardiff’s Antiverse raised £7m in a Series A to scale its AI-driven antibody discovery platform and progress candidates towards later-stage preclinical work. The round will support collaborations with pharma partners and advance internal programmes against challenging membrane protein targets.
Outpost Bio raised £2.6m pre-seed to build automated experimental and modelling platforms that predict drug–microbiome interactions. The funding will accelerate its lab-in-the-loop approach to generate human‑derived functional data for pharma and food partners.
LifeCellsNI secured £590k to establish Northern Ireland’s first HTA‑licensed cryogenic biobank and processing facility. The pre‑seed supports cleanroom installation, licensing and a planned 2026 operational launch.
ROXFIT closed a £1.9m seed round to expand its AI‑powered training and wearable analytics platform for hybrid athletes. The funding will accelerate product development and global ambassador partnerships as the user base scales internationally.
Automating compliance and new payment rails
This week’s fintech and regtech deals focussed on automating compliance and opening new payment rails for property. Startups pitched regulator‑aware AI agents for KYC and AML alongside infrastructure to let tenants use alternative payment methods while preserving standard receipts for landlords.
London’s Diligent AI raised the GBP equivalent of £1.87 million to deploy AI agents that automate KYC and AML workflows for banks and fintechs; the seed will expand product capability and customer teams. Vivox AI raised £1.3 million to scale regulator‑ready modular AI agents for AML, KYC and onboarding workflows, aiming to improve case processing and reduce false positives. Payr secured £1.56 million to enable tenants to pay rent by credit card while ensuring landlords receive standard bank transfers, with funds directed at integrations and partnerships across the UK rental market.
The pattern is clear: seed investors are backing compliance automation and infrastructure plays that could win quick enterprise customers in banking and property, and regulatory requirements are central to product design.
This week's Fintech & Regtech deals:
London‑based Diligent AI raised the GBP equivalent of £1.87m (USD $2.5m) to deploy AI agents that automate KYC and AML workflows for banks and fintechs. The seed will be used to expand product capability and grow the customer and go‑to‑market teams.
Vivox AI raised £1.3m to scale its regulator‑ready modular AI agents for AML, KYC and onboarding workflows. The company will use the funds to expand its enterprise platform and continue deployments that improve case processing and reduce false positives.
Payr raised £1.56m to let tenants pay rent using credit cards while ensuring landlords receive standard bank transfers. The seed will fund integrations and partnerships to roll out its one‑sided payments infrastructure across the UK rental market.
Consumer and SaaS: responsible scaling with auditable AI
Early‑stage capital flowed to consumer brands and workplace and education SaaS this week, with funding aimed at scaling operations, expanding talent networks and building auditable AI for institutional customers. Investors appear to favour growth plans that incorporate governance so customers can adopt AI with confidence.
Belfast luxury gifting brand The Present Tree raised £1.8 million from IFNI and partners to upgrade supply chain systems and open a new headquarters while maintaining a sustainability focus. London’s Ivee secured £745,000 to grow its AI upskilling platform and talent network that certifies AI skills and connects employers with AI‑fluent candidates, accelerating product development and employer partnerships. Leeds‑based Plato raised £260,000 to embed an auditable AI study assistant within university course materials, developing analytics and governance features so institutions can adopt AI while preserving academic oversight.
These deals underline a theme of responsible scaling: investors are supporting operational upgrades and growth, but they are also pressing for auditable, governed AI as a condition for institutional adoption.
This week's Consumer & SaaS (Edtech / HR / B2C) deals:
Belfast luxury gifting brand The Present Tree raised £1.8m to upgrade supply chain, systems and open a new headquarters. The investment from IFNI and partners will help the company scale operations while preserving its sustainability focus.
Ivee raised £745k to grow its AI upskilling platform and talent network that certifies AI skills and connects employers with AI‑fluent candidates. The funding will accelerate product development and expand employer partnerships in the UK and beyond.
Leeds-based Plato raised £260k to embed an auditable AI study assistant within university course materials. The investment will develop analytics and governance features so institutions can adopt AI while preserving academic oversight.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.